Finzati - Logo
CDT logo

CDT Equity Inc.

CDT • Biotechnology
Strong market move
CDT-16.56%
vs. previous close $0.75
$0.63
▼ -0.12 (-16.56%)
Current price
EarningsLatest report: Jun 28, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$24.59M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Healthy liquidity · 1.93Weak profitability
Financial data as of: Jun 28, 2026, 12:00 AM UTCLast earnings update: Jun 28, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:42 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.63
Change-16.56%
Shares Out39.34M
Market Cap$24.59M
Enterprise Value$995.16M
Beta1.49
P/E0.27
P/S0.02
P/B0.02
P/FCF-0.38
EV/Sales0.69
EV/EBITDA4.06

Investment DNA

How strong this company looks for long-term investors

46
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
66/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Healthy liquidity · 1.93Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 3/28/2022
Industry: Biotechnology
P/B i: 0.02
Debt / Equity i: 1.02
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score13 / 20
Debt / Equity: 1.02
Current Ratio: 1.93
Quick Ratio: 1.36
Status: Good

Insider Transactions

Recent executive and insider activity

⚠ 4 high-volume insider sells detected
Taylor Mark Andrew
Transaction: 06/18/2026
SELL
Change
-593,289
Price
$1.40
Filing
06/23/2026
Type
SELL
Regan Andrew
Transaction: 05/13/2026
BUY
Change
+100,000
Price
$1.90
Filing
05/14/2026
Type
BUY
Regan Andrew
Transaction: 03/24/2026
SELL
Change
-147,401
Price
$0.00
Filing
05/14/2026
Type
SELL